Find Out if There is a Child Safety in Pregnancy or Not by Checking Blood
Being a mother is a pleasant feeling, which is surrounded by many difficulties. British experts have claimed to have invented a blood test through which it can be ascertained that there is a danger of miscarriage in pregnant women.
Experts originally developed this test for women who resorted to the IPF process, but they say that naturally pregnant women can do it too This investigation could also be found in the condition of pregnancy. The scientists of Glasgow Center for Reproductive Medicine (GCRM) studied the hormones of two thousand women who were pregnant with IVF technology. They found that women who had low levels of HCG hormone had the high risk of miscarriage.
70 units per liter HCG safe:
Experts found that women who had less than 30 units per liter of HCG hormone in their blood had two percent of their pregnancy reaching eight weeks. Similarly, the rate of women who had 70 hrs per liter of blood was found in the blood, more than 86 percent of their pregnancy was found safe. Marcou Gaudin of GCRM says that after knowing the level of HCG hormone, it can be safely warned about the potential dangers to the joints. This can help in strengthening them mentally and emotionally. This paper will be presented in the annual conference of the European Society of Human Reproduction and Ambulability in Geneva this week.
Tests of breast cancer patients will help determine the level of treatment:
Experts from the University of California have claimed to develop an investigation, with the help of which patients of breast cancer will be able to determine their level of treatment. Experts say that only 15 percent of breast cancer patients are expected to be re-hawked. This test will help them to know whether breast cancer can take them back again or not. In this way, they can avoid going through the more aggressive process of treatment.
The leading researcher, Dr. Laura Esterman, says that it is the first step towards choosing treatments according to the personal status of women suffering from breast cancer. The name of this probe is a mempint and the researchers studied about 652 breast cancer patients about 20 years of data. He estimated 1780 patients whose cancer did not exceed one level and whose carcinogenic tumor size was not more than three centimeters. The results of this research have been published in the journal Joma Oncology.